ARTHUR HALL: Open Payments
NPI 1750772190 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,192 in 58 payments from 17 companies in 2025. Trend: 2023 $1,017 · 2024 $1,025 · 2025 $1,192
Food & beverage: $1,143Education: $49
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $150 |
| BridgeBio Pharma, Inc. | 6 | $139 |
| Actelion Pharmaceuticals US, Inc. | 5 | $138 |
| PFIZER INC. | 9 | $136 |
| Daxor Corporation | 1 | $116 |
| Merck Sharp & Dohme LLC | 6 | $101 |
| CVRx, Inc. | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $39 |
Products named: Attruby, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, VYNDAQEL, BVA-100, OPSUMIT, VERQUVO, Barostim Neo System, WAINUA.
Industry payments across AR — which companies pay providers there.
